A patent review of SCF E3 ligases inhibitors for cancer：Structural design, pharmacological activities and structure–activity relationship-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A patent review of SCF E3 ligases inhibitors for cancer：Structural design, pharmacological activities and structure–activity relationship

Published:2024-11 Issue: Volume:278 Page:116821
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Zeng Jing,Chen Zheng,He Yuxin,Jiang Zhongliang,Zhang Yi,Dong Qin,Chen Liping,Deng Sichun,He Ziyou,Li Ling,Li Jinqi,Shi Jianyou^ORCID

Publisher

Elsevier BV

Reference150 articles.

1. Role of the mitochondrial E3 ubiquitin ligases as possible therapeutic targets in cancer therapy;Di Gregorio;Int. J. Mol. Sci.,2023

2. Structural Diversity of ubiquitin E3 ligase;Toma-Fukai;Molecules,2021

3. An integrative pan-cancer analysis revealing the difference in small ring finger family of SCF E3 ubiquitin ligases;Huang;Front. Immunol.,2022

4. Chemical tools for E3 ubiquitin ligase study;Jing;Chin. Chem. Lett.,2023

5. The role of SCF ubiquitin-ligase complex at the beginning of life;Xie;Reprod. Biol. Endocrinol.,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP